Baiai capsule, a six class new Chinese medicine for hypertension, has been approved for marketing in Yangzijiang Pharmaceutical Group

Baiai capsule is one of the six kinds of new drugs of traditional Chinese medicine for treating hypertension The prescription comes from volume 7-4 shengwan of woman's complete prescription written by Chen Ziming in Song Dynasty This medicine is composed of four kinds of traditional Chinese medicine, such as rehmannia, Platycladus orientalis and Artemisia argyi It has the functions of Nourishing Yin, cooling blood, relieving fire and calming liver It is used to treat primary hypertension of grade one and grade two The syndrome differentiation of traditional Chinese medicine is Yin deficiency and yang hyperactivity, inflammation of liver fire The symptoms are vertigo, headache, weakness of waist and knee, palpitation, red tongue and little moss Compared with Western antihypertensive drugs, it has no toxic side effects and can be taken safely for a long time It has obvious effects on improving symptoms, cardiovascular microcirculation and regulating the function of viscera in patients with hypertension It fills in the blank of pure Chinese medicine without special antihypertensive drugs The project team of Haiyan Pharmaceutical Research Institute has been tackling the technical problems of Baiai capsule for many years, fully optimizing the production process and parameters of each step of the extraction of medicinal materials, such as decocting, volatile oil extraction, concentration, alcohol blending and cream collection, so as to improve the extraction rate of active ingredients and volatile oil At the same time, spray drying technology was used to quickly dry the material into fine powder, which greatly reduced the degradation of effective components Through a series of process optimization, the effective component transfer rate and product yield are greatly improved, which lays a solid foundation for batch production of drugs